Alveolar and bronchial human microphysiological systems for use in respiratory infection research and therapeutics evaluation
Richardson et al
This poster shows the use of two lung models (alveolar and bronchial), which both generate physiologically-relevant phenotypes, to improve preclinical therapeutic evaluation and lung disease models.
A Breath of Fresh Air: Novel approaches to human lung disease modelling for accelerated drug discovery
Webinar Series 5 Episode 1
In this webinar, Professor Wojciech Chrzanowski, University of Sydney, and Dr Emily Richardson, CN Bio, discuss how to accelerate therapeutic discovery and evaluation for respiratory infection and lung injuries, using lung MPS models.
The lung in crisis
Fighting back against pathogens, infections, and inflammation with predictive in vitro respiratory models that accelerate drug discovery.
Animal Models and Microfluidic Tools with a Human Touch
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development – featuring CEO, Dr David Hughes.
This article is taken from GEN Engineering News, May 2022.
ORGAN-ON-A-CHIP – A Novel Way to Accurately Test Delivery of Non-Standard Formulations
A deep dive into our Lung-on-a-chip system with our CEO Dr David Hughes.
This article is taken from Drug Development, January/February 2022.